Renal denervation in treatment-resistant hypertension-Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials

Blood Pressure

Volumn 23, Issue 3, 2014, Pages 135-137

  Kjeldsen, Sverre E ^a   Narkiewicz, Krzysztof ^b   Oparil, Suzanne ^c   Hedner, Thomas ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABLATION THERAPY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; DRUG BLOOD LEVEL; FOLLOW UP; HUMAN; IMPEDANCE CARDIOGRAPHY; KIDNEY DENERVATION; MEDICATION COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; REVIEW; SYMPATHETIC NERVE; CONTROLLED STUDY; HYPERTENSION; INNERVATION; KIDNEY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SYMPATHECTOMY; TREATMENT OUTCOME;

HUMANS; HYPERTENSION; KIDNEY; MEDICATION ADHERENCE; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84901068225     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2014.916896     Document Type: Review

References (16)

1. De la Sier A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistanThypertension classifi ed on the basis of ambulatory blood pressure monitoring. Hypertension. 2011; 57: 889-890
2. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension. Novel implications for an old concept. Hypertension. 2009; 54: 1195-1201
3. Verloop WL, Vink EE, Voskuil M, Vonken EJ, Rookmaaker MB, Bots ML, et al. Eligibility for percutaneous renal denervation: The importance of a systematic screening. J Hypertens. 2013; 31: 1662-1668
4. Symplicity HTN-2 Investigators. R enal sympathetic denervation in patients with treatment-resistanThypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet. 2010; 376: 1903-1909
5. Gifford RW. A n algorithm for the management of resistanThypertension. Hypertension. 1988; 11: I171-175
6. Klein LE. C ompliance and blood pressure control. Hypertension. 1988; 11: I161-164
7. Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Diffi cult-To-control arterial hypertension or uncooperative patients?. The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from nonadherence to recommended therapy. Hypertens Res. 2011; 34: 87-90
8. Kandzari DE, Bhatt DL, Sobotka PA, O N eill WW, Esler M, Flack JM, et al. Catheter-based renal denervation for resistanThypertension: Rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol. 2012; 35: 528-535
9. Bhatt D L, Kandzari D E, O N eill W W, D A gostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistanThypertension. N Engl J Med. 2014; 370: 1393-401
10. Fadl-Elmula FEM, Hoffmann P, Fossum E, Brekke M, Gj ø nn æ ss E, Hj ø rnholm U, et al. Renal sympathetic denervation in patients with treatment-resistanThypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Hypertension. 2013; 62: 526-532
11. Savard S, Frank M, Bobrie G, Plouin P-F, Sapoval M, Azizi M. Eligibility for renal denervation in patients with resistanThypertension: When enthusiasm meets reality in real-life patients. J Am Coll Cardiol. 2012; 60: 2422-2424
12. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, et al. Catheter-based renal nerve ablation and centrally generated sympathetic activity in Diffi cult-To-control hypertensive patients: Prospective case series. Hypertension. 2012; 60: 1485-1490
13. Persu A, Jin Y, Azizi M, Baelen M, Völ z S, Elvan A, et al ., on behalf of the European Network Coordinating research on REnal denervation (ENCOReD). Blood Pressure Changes after Renal Denervation at 10 European Expert Centers. J Hum Hypertens. 2014; 28: 150-156
14. FadLelmula F E, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistanThypertension. Hypertension 2014; 63: 991-999
15. Taler S J, Textor S C, Augustine J E. R esistanThypertension: Comparing hemodynamic management to specialist care. Hypertension. 2002; 39: 982-988. (Pubitemid 34547797
16. Jin Y, Jacobs L, Baelen M, Thijs L, Renkin J, Kefer F J, et al ., on behalf of the Investigator-Steered Project on intravascular Renal Denervation for Management of Drug-ResistanThypertension (INSPiRED) investigators. Rationale and design of the Investigator-Steered Project on intravascular Renal Denervation for Management of Drug-ResistanThypertension (INSPiRED) trial. Blood Press. 2014; 23: 138-146